Industry & Economy 

22 October 2020
ADCs (Anbibody Drug Conjugates) consist of highly potent cytotoxic agents conjugated to antibodies through a specific linker. This molecular format enables the highly selective delivery of any payload to the diseased tissue, while healthy parts of the human body are spared.

Araris Biotech successfully closes seed round

Araris, one of PSIs youngest spin-offs, today announced that they have successfully closed a CHF 15.2M seed round with a group of previous and new investors. The funds raised will allow the further development of the ADC linker technology licensed out by PSI and hopefully identify potent drug candidates.

Dr. Philipp Spycher, CEO of Araris Biotech AG began his entrepreneurial endeavors with the PSI Founder Fellowship that helped kick-start his ideas of building a business around the technology that he helped to develop at PSI.

PSI applauds this development and looks forward to a bright future for Araris.

Read more

  


20120328 Techtransfer 0045.jpg

Technology transfer

PSI strives to make new findings from research accessible to the industry to strengthen the competitiveness of Swiss industrial enterprises. As a result, firms can launch innovations on the market, secure existing jobs and even create new ones.
Schmitt.jpg

Expertise and Services

The Paul Scherrer Institute (PSI) provides a comprehensive range of Research- and Development-Services. Our experts knowledge as well as the qualified laboratories of PSI are appreciated and frequently used by industry.
Anaxam

ANAXAM: Technologytransfer Center for Advanced Manufacturing

The newly founded technology transfer centre ANAXAM forms a bridge between research and industry. Find out here how you can use the new possibilities to optimize products and processes for your company.

GratXray klein.jpg

Spin-off companies

The activities in research and technology at PSI open up a great variety of opportunities for commercial exploitation.
If these technologies or services apply to an entrepreneurial scientist the foundation of a start-up company is a potential next step. PSI fosters and encourages the foundation of spin-off companies through advice and coaching from the transfer centre and with various different support tools.
web PARK innovAARE.jpg

Park innovaare: innovation park @ PSI

Park innovaare is a unique innovation center situated in close proximity to the Paul Scherrer Institute (PSI) and its state-of-the-art accelerator-based large research facilities. Here, driven by the PSI’s expertise, innovations in the fields of accelerator technology, advanced materials and processes, humans and health, and energy are transformed into marketable products and solutions.
Methanolcasale3.jpg

Together with companies

The expertise and infrastructure of the Paul Scherrer Institute (PSI) are open to companies. Many partners have profited from the collaboration with PSI, as shown by the following references.

Contact

Technology Transfer
John Millard

Telephone:
+41 56 310 41 83
E-mail:
techtransfer@psi.ch